TraumaShield

About

Offices

Q&A

What is TraumaShield's primary focus?

TraumaShield is an Israeli startup focused on preventing Post-Traumatic Stress Disorder (PTSD) by developing an innovative first-aid device.

When was TraumaShield founded?

TraumaShield was founded in 2026.

What type of product is TraumaShield developing?

TraumaShield is developing a first-aid device that delivers an FDA-approved compound immediately after trauma to disrupt fear-memory consolidation and prevent PTSD, depression, and anxiety.

Which sector does TraumaShield primarily operate in?

TraumaShield's primary sector is HealthTech.

Who are the co-founders of TraumaShield?

The co-founders of TraumaShield are David Slobodiansky, who serves as CEO, and Dr. Daniel Kolsky, M.D., who is the Clinical Lead.

Has TraumaShield received any funding?

In 2026, TraumaShield received a Grant from Mamram Lift 2 and D.Tech by SouthUp.

Who are some key executives at TraumaShield?

Key executives at TraumaShield include Prof. Joseph Zohar, M.D., as Medical Officer, and Prof. Eyal Fruchter, M.D., as VP Clinical Ops.

What are the target customer segments for TraumaShield's product?

TraumaShield targets first responders, military personnel, hospitals, and trauma centers.

Team · 13

David Slobodiansky

Founder · Co-founder, CEO

Dr. Daniel Kolsky, M.D.

Founder · Co-founder, Clinical Lead

Prof. Joseph Zohar, M.D.

CMO

Prof. Eyal Fruchter, M.D.

VP Clinical Operations & Clinical Advisory

Dr. Shi Yarkoni, Ph.D., M.D., MBA

Business and Strategy Advisory

Amos Ofer, Ph.D., MBA

Business and Strategy Advisory

Oz Malkesman, Ph.D., MBA

Future CBO

Dr. Danny J. Lee, M.D.

Regulatory & Development

Dr. Tali Gorfine, M.D., Ph.D.

Clinical Development

Gil Bachar, Ph.D.

Technical Lead

Dr. Mihael Bazhmin, M.D., MHA

Psychiatric Administration

Dr. Renana Eithan M.D.

Psychiatrist & Neuroscientist

Barbara Olasov Rothbaum, PhD

Director of the Emory Healthcare Veterans Program

Sectors & technology